Darrick Carter

Darrick Carter

Darrick Carter, PH.D, is the Vice President of Adjuvant Technology at IDRI, a nonprofit global health organization that takes a comprehensive approach in order to combat infectious diseases. IDRI combines the high-quality science of a research organization with the product development capabilities of a biotech company to create new diagnostics, drugs and vaccines. Founded in 1993, IDRI has 125 employees headquartered in Seattle with nearly 100 partners/collaborators around the world. For more information, visit www.idri.org.

Recent posts

Slowing the Global Spread of Climate-Sensitive Infectious Diseases
Climate change is already suspected of causing legions of deaths every year as a result of extreme weather events: heat waves and floods; degradation of water supplies and sanitation with negative... Read more »

Page 1 of 1

Underwriters and Partners

Xpertise: Watch + Learn

Sponsored · Whitepaper
Monitoring Solutions for Pharma-CRO/CMO Partnerships to Maintain Quality & Timelines
Implementing electronic solutions for risk mitigation
XiltriX

Xconomy Insight · Webinar
The New Era of Emerging Therapies Webinar Series
Potential cures and treatments for diseases are on the horizon for a growing number of patients, thanks to recent breakthroughs in CRISPR gene-editing technologies and in cell and gene therapy.

Xconomy Insight · Special Report
How to Jump 5 Unforeseen Hurdles to Biotech Success – Startup Sourcebook
Insights, wisdom, and inspiration on what it takes

From Our Advertisers

Investment in Wisconsin startups reaches new record total
Tax credits help tech innovators attract capital, fuel growth
Wisconsin Economic Development Corporation

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

IDG Tech Network

Protected by Carbonite

Eventbrite - events made easy